title: Biovigilance and pharmacovigilance for haemophilia.
authors.affiliation: Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA.
authors.forename: M
authors.initials: M
authors.lastname: Weinstein
authors.forename: M
authors.initials: M
authors.lastname: Makris
authors.forename: C A
authors.initials: CA
authors.lastname: Ludlam
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D001779:Blood Coagulation Factors / Q000009:adverse effects*; D005060:Europe; D014943:Global Health; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D009656:North America; D011358:Product Surveillance, Postmarketing; D012308:Risk Management
chemical_list: D001779:Blood Coagulation Factors